Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $35.23 ($1.4M) on 2019-05-13, disclosed to the SEC on 2019-05-15.
Seasonal sale ($1.4M) by Chief Executive Officer — this insider has traded FGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.23 | 6,200 | $218K | 15.2% |
| 2 | $35.52 | 918 | $33K | 2.3% |
| 3 | $36.07 | 11,500 | $415K | 28.8% |
| 4 | $36.21 | 500 | $18K | 1.3% |
| 5 | $36.92 | 700 | $26K | 1.8% |
| 6 | $36.40 | 6,350 |
| $231K |
| 16.0% |
| 7 | $36.77 | 1,100 | $40K | 2.8% |
| 8 | $37.12 | 12,050 | $447K | 31.1% |
| 9 | $37.37 | 318 | $12K | 0.8% |
| Total | $36.34 avg | 39,636 | $1.4M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |